SION (SION) reported D&A of $154K in Q1 2026.

How has SION's D&A changed year-over-year?

SION's D&A decreased by 3.1% year-over-year, from $159K to $154K.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

SION SION D&A

D&A at other companies

Vertex PharmaceuticalsVRTX

$55.9M+15.5%

Septerna, Inc.SEPN

$421K+6.0%

BioCryst PharmaceuticalsBCRX

$461K+39.3%

Denali Therapeutics Inc.DNLI

$2.85M+22.4%

Neurocrine BiosciencesNBIX

$7.2M+9.1%

Other financials

Income statement

See full

Operating income-$29.6M-50.6%

Net income-$26.8M-62.5%

EPS (diluted)-$0.60+3.2%

Balance sheet

See full

Cash & equivalents$64.3M-23.2%

Total debt$8.4M-11.8%

Total equity$288.2M-18.1%

Total assets$305.0M-17.5%

Cash flow

See full

Operating cash flow-$21.8M-34.1%

CapEx--100%

Free cash flow-$21.8M-33.4%

Valuation

See full

Market cap$1.86B—

Returns & leverage

See full

Return on equity-26.7%—

Debt / equity0×0.0×

Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is SION's D&A?: SION (SION) reported D&A of $154K in Q1 2026.
How has SION's D&A changed year-over-year?: SION's D&A decreased by 3.1% year-over-year, from $159K to $154K.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.